Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Cardinal Health Inc. recalls Xolair (omalizumab injection)

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.
Products
  • Xolair (omalizumab injection)
Where it was sold

Nationwide Within the U.S.

Nationwide

Units affected
6 units
About this recall
Xolair (omalizumab injection), 150 mg/ml, 1 auto-injector, Rx only, Genentech, Inc, South San Francisco, CA 9408, NDC: 50242-215-55.